Otonomy Priced, Nasdaq: OTIC
Late-stage biotech developing sustained-exposure treatments for ear diseases.
Industry: Health Care
First Day Return: +7.2%
Industry: Health Care
OTIC
Late-stage biotech developing sustained-exposure treatments for ear diseases.
| IPO Data | |
|---|---|
| IPO File Date | 07/11/2014 |
| Offer Price | $16.00 |
| Price Range $14.00 - $16.00 | |
| Offer Shares (mm) | 6.3 |
| Deal Size ($mm) | $100 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 08/12/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $100 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | San Diego, CA, United States |
| Founded | 2008 |
| Employees at IPO | 31 |
| Website www.otonomy.com | |
IPO News for Otonomy
Otonomy (OTIC) Performance
